Pregabalin misuse‐related ambulance attendances in Victoria, 2012–2017: characteristics of patients and attendances

Abstract

Objective To compare changes in pregabalin prescribing and misuse‐related ambulance attendances; to characterise the patients attended by paramedics for pregabalin misuse‐related harms; to assess the association of pregabalin misuse with use of other sedatives and with suicidal ideation and self‐harm; to compare the characteristics of pregabalin misuse‐related harms in people who misuse pregabalin according to whether or not they also used other sedatives. Design, setting, participants Retrospective analysis of data on ambulance attendances in Victoria, January 2012 – December 2017, for which pregabalin misuse‐related harms were a contributing factor. Main outcome measures Rates of pregabalin misuse‐related ambulance attendances, pregabalin prescription rates (each 6‐monthly); patient characteristics, including age, sex, history of drug misuse or psychiatric problems, concurrent use of other sedatives, and current suicidal ideation and self‐harm. Results There were 1201 pregabalin misuse‐related attendances during the study period; the rate increased from 0.28 cases per 100 000 population in the first half of 2012 to 3.32 cases per 100 000 in the second half of 2017. The attendance rate was strongly correlated with prescription rates in Australia (r = 0.90; P = 0.001). 593 attendances (49%) were for people with a history that may have contraindicated prescribing pregabalin. Pregabalin was frequently misused with other sedatives (812 attendances, 68%), particularly benzodiazepines (440, 37%); 472 attendances (39%) were associated with suicide attempts. People who misused pregabalin with other sedatives more frequently presented with moderate to severe impairments of consciousness, but the frequency of suicide attempts was similar whether other sedatives were concurrently used or not. Conclusions Rates of pregabalin misuse‐related ambulance attendances in Victoria have increased markedly over the past 6 years. Caution is required when prescribing pregabalin for people taking other sedatives. Limiting the dispensing of this drug may reduce the risks associated with its misuse.

Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018

“…Data are from the previously described National Ambulance Surveillance System . Briefly, electronic patient care records (ePCR), computer‐aided dispatch and other clinical details are provided to Turning Point for data cleaning, validation and coding by specialist research assistants using a systematic and validated coding method .…”

Recent trends in heroin and pharmaceutical opioid‐related harms in Victoria, Australia up to 2018

“…Ambulance records were collected and coded as part of the Ambo Project, a collaboration between Ambulance Victoria and Turning Point (a national addiction treatment, research and education centre). The methods of this project have been described previously and are briefly outlined below.…”

TheMJAin 2019: going from very good to great!

“…The findings suggest that availability should be restricted by, for example, reducing pack sizes for non‐prescription paracetamol. The increasing misuse of the anticonvulsant pregabalin, widely used for treating neuropathic pain, is associated with adverse psychiatric and medical effects. In their retrospective cross‐sectional study, Crossin and her colleagues found that the rate of pregabalin‐related ambulance attendances increased tenfold in Australia between 2012 and 2017, and that the rise was correlated with the national prescription rate. Patients frequently misused pregabalin together with other sedatives, particularly benzodiazepines, and almost 40% of misuse‐related events requiring paramedic attendance were suicide attempts.…”